🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Pneumococcal conjugate vaccine Synflorix (GSK1024850A)

Found 26 matching trials

Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines

PHASE3

The purpose of this observer blind study is to assess the safety in terms o...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-10-22

Trial ID

NCT00547248

Treatments Being Tested

Synflorix Tritanrix-HepB Hiberix Polio Sabin Poliorix Prevenar (Wyeth)

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine

PHASE3

This study will evaluate safety, reactogenicity and immunogenicity of GSK B...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-08-07

Trial ID

NCT00344318

Treatments Being Tested

Pneumococcal conjugate vaccine GSK1024850A Prevenar Tritanrix-HepB Hiberix Polio Sabin.Poliorix.

COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine

PHASE3

This is a study in a large number of healthy children less than 3 years old...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-06-28

Trial ID

NCT00466947

Treatments Being Tested

Pneumococcal conjugate vaccine GSK1024850A Havrix Engerix-B Infanrix hexa GSK Biologicals' DTPa-IPV/Hib vaccine

Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™

PHASE3

The purposes of this study are: To demonstrate the immunogenicity in terms...

Status

Completed

Location

GSK Investigational Site

Start Date

2008-06-10

Trial ID

NCT00680914

Treatments Being Tested

Pneumococcal vaccine GSK1024850A (Synflorix)Prevenar GSK Biologicals' Hiberix™

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age

PHASE3

The purpose of the present study is to demonstrate that the changes in the ...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-01-05

Trial ID

NCT00808444

Treatments Being Tested

Pneumococcal conjugate vaccine GSK1024850A (different lots)Infanrix hexa Infanrix-IPV/Hib Rotarix

A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants

PHASE3

The primary aim of the study is to demonstrate that an investigational 4-do...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-06-11

Trial ID

NCT02447432

Treatments Being Tested

Pneumococcal vaccine GSK1024850A (10Pn-PD-DiT) vaccine (4-dose presentation)Pneumococcal vaccine GSK1024850A (10Pn-PD-DiT) vaccine (1-dose presentation)DTPw-HBV/Hib

Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria

PHASE3

The purpose of this trial is to assess the safety, reactogenicity and immun...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-10-04

Trial ID

NCT01153893

Treatments Being Tested

Pneumococcal vaccine GSK1024850A InfanrixTM

Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines

PHASE3

This protocol posting deals with objectives \& outcome measures of an exten...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-05-14

Trial ID

NCT00891176

Treatments Being Tested

MenitorixTM Pneumococcal conjugate vaccine GSK1024850A PrevenarTM MeningitecTM NeisVac-CTM InfanrixTM hexa InfanrixTM penta InfanrixTM IPV/Hib InfanrixTM IPV

Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A

PHASE3

The aim of this study is to assess the effectiveness of GSK Biologicals' pn...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-02-18

Trial ID

NCT00839254

Treatments Being Tested

Pneumococcal conjugate vaccine Synflorix (GSK1024850A)GSK Biologicals' Engerix TM vaccine (Hepatitis B vaccine)GSK Biologicals' Havrix TM vaccine (Hepatitis A vaccine)

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age

PHASE3

The purpose of this study is to assess the immunogenicity in terms of antib...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-09-18

Trial ID

NCT00533507

Treatments Being Tested

Synflorix Infanrix hexa Rotarix

Previous Next